当前位置: X-MOL 学术Lancet Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
New therapy for children with plexiform neurofibromas.
The Lancet Oncology ( IF 41.6 ) Pub Date : 2020-03-26 , DOI: 10.1016/s1470-2045(20)30206-0
Elizabeth Gourd

Children with neurofibromatosis type 1 and inoperable plexiform neurofibromas might have durable tumour shrinkage and clinical benefit with selumetinib, according to a phase 2 .

中文翻译:

儿童丛状神经纤维瘤的新疗法。

根据第2阶段,患有1型神经纤维瘤病和无法手术的丛状神经纤维瘤的儿童可能会出现持久的肿瘤缩小和selumetinib的临床获益。
更新日期:2020-03-27
down
wechat
bug